AAIPharma
AAIPharma establishes new business unit, expands clinical development operations
Published in Disease Risk Factor Week, October 22nd, 2006
The acquisition of CAC provides AAIPharma with additional therapeutic expertise, while further strengthening its global clinical development business.
With over 10 years of international experience in all clinical phases of oncology drug development, CAC has extensive experience in performing lead assessment of new analogues of established drugs as well as novel target-oriented compounds. The company has developed expertise in a wide...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- American Psychological Association
Short term, targeted approach is best way to encourage weight loss in teens, stud shows - Business Update
Anthem Blue Cross and Blue Shield in Virginia launches 360 Degree Health - Centers for Disease Control and Prevention, U.S.
Lung function test guidelines for respiratory hazard-exposed individuals are presented - Centers for Disease Control and Prevention, U.S.
Recent studies from the United States and Japan add new data to meningitis research - AMD Alliance International
Eye disease can lead to depression and suicide - Aarhus University Hospital, Aarhus, Denmark
Researchers' findings from Denmark, Japan and the United States advance cardiology research - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
